etalocib drug candidate development treatment various types acts leukotriene receptor antagonist pparÎ³ clinical trials conducted measuring efficacy treatment nonsmall cell lung cancer pancreatic cancer inflammatory conditions asthma psoriasis ulcerative colitis suspended due lack antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikietalocib